Risk of Clade II Mpox Associated with Intimate and Nonintimate Close Contact Among Men Who Have Sex with Men and Transgender Adults — United States, August 2022–July 2023
Chard A, Dalton A, Diallo A, Moulia D, Deputy N, Zecca I, Quilter L, Kachur R, McCollum A, Rowlands J, Britton A, Fisher R, Chai S, Licherdell E, Still W, Morris A, Castilho J, Markus T, Morrow A, Danza P, Hansen A, Ali S, Wegner C, Weber R, Betancourt G, Zipprich J, Sutton M, Pathela P, Hawkins S, Wendel K, Feldstein L. Risk of Clade II Mpox Associated with Intimate and Nonintimate Close Contact Among Men Who Have Sex with Men and Transgender Adults — United States, August 2022–July 2023. MMWR Morbidity And Mortality Weekly Report 2024, 73: 896-902. PMID: 39388387, PMCID: PMC11466375, DOI: 10.15585/mmwr.mm7340a2.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentAdultCase-Control StudiesHomosexuality, MaleHumansMaleMiddle AgedRisk AssessmentSARS-CoV-2Transgender PersonsUnited StatesYoung AdultConceptsCondomless receptive anal sexReceptive anal sexAnal sexUnited StatesCase-patientsControl patientsAssociated with sexual contactSex practicesSexually active personsTransgenderAssociated with transmissionSexual contactAdjusted oddsMSMMenVaccination coverageActive personsNonintimatesVaccinePatientsMpoxVaccine promotionMultifaceted approachSexIntimate